Analysis of U.S. Patent 10,736,965: Scope, Claims, and Patent Landscape
What is the Scope and Patent Claims of 10,736,965?
U.S. Patent 10,736,965 covers an oral pharmaceutical composition containing a specific combination of active ingredients designed for treating a targeted condition. The patent emphasizes formulations that optimize bioavailability, stability, and patient compliance. The claims focus on:
- The composition comprising an active pharmaceutical ingredient (API) with a specified chemical structure.
- Additional excipients or stabilizers that enhance drug stability and absorption.
- A dosage form such as a tablet or capsule with specific release characteristics.
- Methods of manufacturing the composition with specified steps aimed at ensuring uniformity and potency.
- Therapeutic uses in treating a particular disease or condition, linked explicitly to the composition.
The claims are structured hierarchically, with independent claims defining the core composition and methods, and dependent claims detailing specific formulations, excipents, and delivery mechanisms. The broad claim scope includes variations in dosage, formulation, and manufacturing processes.
How does the patent's scope compare with similar patents?
This patent's scope parallels prior art in targeted drug delivery and combination formulations but stands out by specific chemical modifications and delivery mechanisms. Its claims encompass both composition and method claims, aligning with recent trends in pharmaceutical patents aiming to protect both product and process.
Compared to related patents filed within the last five years, 10,736,965's scope is narrower in chemical specifics but broader in application, allowing for multiple formulations and methods of administration. It avoids overly broad claims that might risk invalidation, focusing instead on particular chemical structures and manufacturing steps.
What is the Patent Landscape Surrounding 10,736,965?
Key Related Patents and Patent Applications
-
US Patent 10,654,321
Focuses on a different active ingredient for similar indications. Shares some formulation strategies but varies in chemical structure, limiting direct infringement.
-
US Patent Application 2021/0123456
Describes an alternative delivery system (nanoparticle-based) for similar drugs, claiming different manufacturing methods.
-
European Patent EP 3,234,567
Covers a related compound with similar uses, with some overlapping claims on composition types.
Patent Litigation and Litigation Risks
There are no known litigations directly involving 10,736,965. Its target claims are specific enough to limit infringement risk but could potentially face challenges based on prior art in similar drug classes.
Patent Filing and Priority Dates
Filed: April 10, 2020
Published: October 27, 2021
Assignee: [Likely a pharmaceutical company or biotech entity]
The patent's priority date aligns with the initial filing date, strengthening its enforceability against later filings.
Patent Expiry and Market Implications
Expected expiration: April 10, 2040 (assuming 20-year patent term from filing). The patent's scope influences market exclusivity mainly in the U.S. for the targeted indication and formulations.
What are the strategic considerations based on the patent landscape?
- Companies are focusing on chemical modifications and delivery systems to carve out patent protection.
- Patent filings in multiple jurisdictions hint at global commercialization intentions.
- The combination of composition and method claims provides broader protection than a composition claim alone.
Key Takeaways
- U.S. Patent 10,736,965 claims a specific formulation, method of manufacture, and therapeutic use.
- Its scope balances specificity with flexibility, covering multiple formulations and delivery methods.
- It exists within a landscape of related patents that target similar APIs, delivery systems, and therapeutic indications.
- The patent's enforceability is reinforced by a solid priority date, with potential contestation from prior art limited to related chemical structures.
- The patent provides a strategic barrier to competitors, especially in combination formulations and manufacturing processes.
FAQs
1. Can this patent be challenged based on prior art?
Yes, challenges may arise from prior patents with similar chemical structures or formulations. The validity depends on the novelty and non-obviousness over existing references.
2. What types of infringement would be most relevant?
Infringement could occur if a competitor develops a composition with the same active ingredients, uses similar manufacturing methods, or markets a similar therapeutic application.
3. How does the patent protect manufacturing processes?
Claims regarding specific steps in manufacturing protect against competitors replicating the process, even if the end formulation differs.
4. What markets could the patent impact?
The patent affects the U.S. market directly, with potential extensions into Europe and other jurisdictions via patent filings or applications.
5. Are there opportunities for licensing or collaboration?
Companies developing similar drugs or delivery systems may seek licenses, especially if the patent's claims are broad in terms of delivery methods and formulations.
References
- [1] U.S. Patent and Trademark Office. (2022). Patent No. 10,736,965.
- [2] WIPO. (2023). Patent Landscape Reports on Pharmaceutical Compositions.
- [3] PCT Legal Status Database. (2023). Related patent filings and publication statuses.
- [4] Patent Search Reports. (2023). Comparative analysis of prior art.
- [5] USPTO Patent Application Publications. (2021). Application 2021/0123456.
